Clinical Trials in Hunan, China
11 recruiting
Showing 1–20 of 24 trials
Recruiting
Phase 3
Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage
Intracerebral Hemorrhage
Beijing Tiantan Hospital1,192 enrolled41 locationsNCT07338175
Recruiting
Phase 3
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
LeonaBio500 enrolled224 locationsNCT05696626
Recruiting
Not Applicable
Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy
Pancreatitis, ChronicPancreatitis, AcutePancreatic Duct Stones
Changhai Hospital1,250 enrolled10 locationsNCT07202559
Recruiting
Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Astellas Pharma Global Development, Inc.900 enrolled241 locationsNCT02960022
Recruiting
Phase 1Phase 2
A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors
Advanced Solid Tumor
BioNTech SE375 enrolled16 locationsNCT07147348
Recruiting
Phase 1Phase 2
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Colorectal, CancerCervical CancerLung Cancer+4 more
Sichuan Enray Pharmaceutical Sciences Company54 enrolled9 locationsNCT07433283
Recruiting
Phase 1
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma
Shanghai Henlius Biotech174 enrolled69 locationsNCT07160335
Recruiting
Phase 2
Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
Advanced NSCLC
Shanghai Junshi Bioscience Co., Ltd.66 enrolled18 locationsNCT06924606
Recruiting
Phase 1Phase 2
A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
Solid Tumor
Advenchen Laboratories, LLC228 enrolled15 locationsNCT07392736
Recruiting
Phase 1
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
Advanced Solid Tumor
Daiichi Sankyo210 enrolled38 locationsNCT06244485
Recruiting
Not Applicable
SV With TTPEE Measurement Predicts Upper Airway Patency in Prolonged Tracheostomy Patients
Tracheostomy
Capital Medical University300 enrolled5 locationsNCT07107243
Recruiting
Phase 3
Efficacy of Montelukast on STEMl Patients
Myocardial Infarction (MI)
Shanghai Zhongshan Hospital512 enrolled12 locationsNCT07320625
Recruiting
Phase 1Phase 2
A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors
Non-small Cell Lung CancerSolid Tumor Cancer
Shanghai Henlius Biotech105 enrolled3 locationsNCT06848699
Recruiting
Not Applicable
Evidence-based Practice in the Management of Gastric Tube Placement in Children
NursingHospitalized ChildrenEnteral Nutrition Therapy
Children's Hospital of Fudan University2,750 enrolled22 locationsNCT07038538
Recruiting
Phase 3
Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above
Tuberculosis
Chengdu CoenBiotech Co., Ltd1,784 enrolled8 locationsNCT07152639
Recruiting
Phase 2
A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC
Metastatic Castration-resistant Prostate Cancer (mCRPC)
MediLink Therapeutics (Suzhou) Co., Ltd.100 enrolled24 locationsNCT06241846
Recruiting
Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy
Multiple System Atrophy - Parkinsonian Subtype (MSA-P)Multiple System Atrophy - Cerebellar Subtype (MSA-C)
Min Zhao,MD90 enrolled1 locationNCT06890377
Recruiting
TSPO PET in the Evaluation of Neuroinflammation in Patients with Multiple System Atrophy
Multiple System Atrophy - Parkinsonian Subtype (MSA-P)Multiple System Atrophy - Cerebellar Subtype (MSA-C)
Min Zhao,MD90 enrolled1 locationNCT06890390
Recruiting
Phase 2
A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy
Carcinoma, Hepatocellular
Shanghai Henlius Biotech90 enrolled1 locationNCT06742892
Recruiting
Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.
Pancreatic CancerDiagnosisPrognosis+2 more
The Third Xiangya Hospital of Central South University50 enrolled1 locationNCT06655233